Equity focused in-depth technical reports.
Research
Rachel Kensington Senior Equity Analyst · Blue Ocean Trading Solutions Technical Overview Palantir (PLTR) reclaimed its 20-week EMA at $151.82 on Wednesday, closing at $152.61 with price confirming above the 10-day EMA at $144.55. That combination — price crossing the higher-timeframe EMA with the 10-day confirming on the same
Research
Rachel Kensington Equities Analyst · Blue Ocean Trading Solutions Published April 21, 2026 · LLY · Healthcare / Pharma 1. Technical Overview Eli Lilly (LLY) printed a fresh 2TFE short signal at Monday's close, breaking below both its 10-day EMA at $923 and its 20-week EMA at $961 for a sustained third
Research
Published April 15, 2026 | Equities | AMZN | Initiation Coverage Rachel Kensington Senior Equity Analyst · Blue Ocean Trading Solutions 1. Technical Overview Amazon closed April 14 at $249.02, trading 12.5% above its 20-week EMA at $221.27 — comfortably established in bullish posture with the initial cross confirmed. The structural picture
Research
SBA Communications surges 19% on confirmed M&A interest from Blackstone, KKR, and Brookfield. Weekly posture flipped bullish on 6.6x volume -- but the entry at $204 is not the opportunity.
Research
KODK surges 20% to a 52-week high on 6.6x average volume, clearing $10 for the first time since 2021. Bullish above the 20-week EMA, but RSI at 82 demands discipline.
Equities
Nike collapsed 15.5% on 6.5x volume after Q3 earnings. Continuation short confirmed — below 20-week EMA and 10-day EMA. Target $38–$40, stop $48.50, R:R 1.7:1.
Equities
Apellis Pharmaceuticals surges 135% on Biogen’s $41/share acquisition offer. Full technical and fundamental breakdown of the deal and what it means for the tape.
Equities
IONR surged on a federal court victory for Rhyolite Ridge. Technical analysis of the reversal setup, key levels, and what the critical minerals macro backdrop means for this Nevada lithium developer.
Equities
IDN surged 25% on record Q4 2025 earnings and first-ever operating profitability. Price sits well above the 20-week EMA — the setup favors longs on pullbacks.
Equities
AGX surges 38% on record Q4 earnings. Structural posture is bullish above 20-week EMA. RSI at 68, $2.9B backlog. Key levels, risk/reward, and full analysis inside.
Equities
WVE cratered 49.6% on INLIGHT dose-response data. RSI at 19.41, volume 15x average — is this capitulation or the beginning of further downside? Rachel Kensington lays out the levels.
Equities
OLPX surged 51% on Henkel’s $1.4B acquisition offer at $2.06/share. Rachel Kensington breaks down the merger arb setup, deal risk, and the invalidation level to watch.